Hong Kong stocks surged again, with Beihai Kangcheng-B (01228.HK) rising by nearly 17%, accumulating more than 15 times in the year. The company recently received a strategic subscription from Baiyang Medicine.

According to the AI Finance App, Beihai Kangcheng-B (01228.HK) has surged nearly 17% again, with a year-to-date cumulative increase of over 1500%. As of the time of writing, it has risen by 14.36% to 2.23 Hong Kong dollars, with a trading volume of 41.075 million Hong Kong dollars.